Form 4: Conduit Pharmaceuticals Insider Reports Stock Transaction
Insider Transaction (Form 4)
Andrew Regan and 1 other reported changes in beneficial ownership of Conduit Pharmaceuticals Inc. common stock on October 22, 2026.
Summary
- Other acquisition/disposition: acquired 499,616 Common Stock on October 23, 2026; holds 499,618 after (Direct).
- Other acquisition/disposition: acquired 1,347,616 Common Stock on October 22, 2026; holds 1,347,619 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew Regan — 10% owner
Corvus Capital Ltd. — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-23 | Other acquisition/disposition | Common Stock | 499,616 | — | — | 499,618 |
| 2026-10-22 | Other acquisition/disposition | Common Stock | 1,347,616 | — | — | 1,347,619 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-23 | Other acquisition/disposition (499,616 shares) |
| 2026-10-22 | Other acquisition/disposition (1,347,616 shares) |
Keywords
insider transaction, Form 4, CDT, CDT Equity Inc., neutral, Andrew Regan, Corvus Capital Ltd.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.